ArticleMaterials (Basel, Switzerland)2022
The Mechanical Properties Prediction of Poly [(3-hydroxybutyrate)-co-(3-hydroxyvalerate)] (PHBV) Biocomposites on a Chosen Example.
Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Potential of Biodegradable Polyhydroxyalkanoates for the Construction of Sustainable Polymer Composite Materials.Polymers · 2026Article
- Processing of Layered Composite Products Manufactured on the Basis of Bioresin Reinforced with Flax Fabric Using Milling Technology.Materials (Basel, Switzerland) · 2024Article
- Reprocessing Possibilities of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-Hemp Fiber Composites Regarding the Material and Product Quality.Materials (Basel, Switzerland) · 2023Article
- Article
- Engineered Highly Porous Polyvinyl Alcohol Hydrogels with Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and Graphene Nanosheets for Musculoskeletal Tissue Engineering: Morphology, Water Sorption, Thermal, Mechanical, Electrical Properties, and Biocompatibility.Materials (Basel, Switzerland) · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper aims to experimentally determine the properties of the poly [(3-hydroxybutyrate)-co-(3-hydroxyvalerate)]-(PHBV)-30% hemp fiber biocomposite, which is important in terms of numerical simulations of product manufacturing, and to evaluate the mechanical properties by means of micromechanical modeling. The biocomposite was manufactured using a single-screw extruder. Specimens for testing were produced by applying the injection molding technology. Utilizing the simulation results of the plastic flow, carried out by the Moldflow Insight 2016 commercial software and the results of experimental tests, the forecasts of selected composite mechanical properties were performed by means of both numerical and analytical homogenization methods. For this purpose, the Digimat software was applied. The necessary experimental data to perform the calculations for the polymer matrix, fibers, and the biocomposite were obtained by rheological and thermal studies as well as elementary mechanical tests. In the paper, the method of determining selected properties of the biocomposite and the method of forecasting its other properties are discussed. It shows the dependence of the predicted, selected properties of the biocomposite on the filler geometry assumed in the calculations and the homogenization method adopted for the calculations. The results of the work allow for the prediction of properties of the PHBV biocomposites-hemp fiber for any amount of filler used. Moreover, the results allow for the estimation of the usefulness of homogenization methods for the prediction of properties of the PHBV-hemp fiber biocomposites. Furthermore, it was found that for the developed and tested biocomposites, the most effective possibility of mechanical properties prediction is using the Mori-Tanaka homogenization model, which unfortunately has some limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.